Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypocretins Regulate the Anxiogenic-Like Effects of Nicotine and Induce Reinstatement of Nicotine-Seeking Behavior
Ainhoa Plaza‐Zabala, Elena Martín‐García, Luı́s de Lecea, et al.
Journal of Neuroscience (2010) Vol. 30, Iss. 6, pp. 2300-2310
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress
John R. Mantsch, David L. Baker, Douglas Funk, et al.
Neuropsychopharmacology (2015) Vol. 41, Iss. 1, pp. 335-356
Open Access | Times Cited: 414
The hypocretins/orexins: integrators of multiple physiological functions
Jingcheng Li, Zhian Hu, Luı́s de Lecea
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 332-350
Open Access | Times Cited: 229
Corticotropin releasing factor: A key role in the neurobiology of addiction
Eric P. Zorrilla, Marian L. Logrip, George F. Koob
Frontiers in Neuroendocrinology (2014) Vol. 35, Iss. 2, pp. 234-244
Open Access | Times Cited: 226
The neurobiological basis of narcolepsy
Carrie E. Mahoney, Andrew C. Cogswell, Igor J. Koralnik, et al.
Nature reviews. Neuroscience (2018) Vol. 20, Iss. 2, pp. 83-93
Open Access | Times Cited: 216
A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
Morgan H. James, Stephen V. Mahler, David E. Moorman, et al.
Current topics in behavioral neurosciences (2016), pp. 247-281
Closed Access | Times Cited: 169
The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163
Multiple roles for orexin/hypocretin in addiction
Stephen V. Mahler, Rachel J. Smith, David E. Moorman, et al.
Progress in brain research (2012), pp. 79-121
Open Access | Times Cited: 211
Orexin/hypocretin role in reward: implications for opioid and other addictions
Corey Baimel, Selena E. Bartlett, Lih‐Chu Chiou, et al.
British Journal of Pharmacology (2014) Vol. 172, Iss. 2, pp. 334-348
Open Access | Times Cited: 168
Tobacco addiction and the dysregulation of brain stress systems
Adriaan W. Bruijnzeel
Neuroscience & Biobehavioral Reviews (2012) Vol. 36, Iss. 5, pp. 1418-1441
Open Access | Times Cited: 156
Physiology of the orexinergic/hypocretinergic system: a revisit in 2012
Jyrki P. Kukkonen
AJP Cell Physiology (2012) Vol. 304, Iss. 1, pp. C2-C32
Closed Access | Times Cited: 133
The Hypocretin/Orexin System Mediates the Extinction of Fear Memories
África Flores, Victòria Valls-Comamala, Giulia Costa, et al.
Neuropsychopharmacology (2014) Vol. 39, Iss. 12, pp. 2732-2741
Open Access | Times Cited: 119
Role of cues and contexts on drug‐seeking behaviour
Christina J. Perry, Isabel Zbukvic, Jee Hyun Kim, et al.
British Journal of Pharmacology (2014) Vol. 171, Iss. 20, pp. 4636-4672
Open Access | Times Cited: 115
The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia
Paul J. Coleman, Anthony L. Gotter, W. Joseph Herring, et al.
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 509-533
Closed Access | Times Cited: 113
The hypocretin (orexin) system: from a neural circuitry perspective
Shi‐Bin Li, Luı́s de Lecea
Neuropharmacology (2020) Vol. 167, pp. 107993-107993
Closed Access | Times Cited: 111
Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders
Morgan H. James, Erin J. Campbell, Christopher V. Dayas
Current topics in behavioral neurosciences (2017), pp. 197-219
Open Access | Times Cited: 102
Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats
Elizabeth A. Lungwitz, Andrei I. Molosh, Philip L. Johnson, et al.
Physiology & Behavior (2012) Vol. 107, Iss. 5, pp. 726-732
Open Access | Times Cited: 103
Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms
H Le-Niculescu, Yokesh Balaraman, Sahil D. Patel, et al.
Translational Psychiatry (2011) Vol. 1, Iss. 5, pp. e9-e9
Open Access | Times Cited: 95
New mechanisms and perspectives in nicotine withdrawal
Kia J. Jackson, Pretal P. Muldoon, Mariella De Biasi, et al.
Neuropharmacology (2014) Vol. 96, pp. 223-234
Open Access | Times Cited: 92
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
Jiann Wei Yeoh, Erin J. Campbell, Morgan H. James, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 86
Intravenous nicotine self-administration and cue-induced reinstatement in mice: Effects of nicotine dose, rate of drug infusion and prior instrumental training
Christie D. Fowler, Paul J. Kenny
Neuropharmacology (2011) Vol. 61, Iss. 4, pp. 687-698
Open Access | Times Cited: 85
Hypocretin/Orexin Signaling in the Hypothalamic Paraventricular Nucleus is Essential for the Expression of Nicotine Withdrawal
Ainhoa Plaza‐Zabala, África Flores, Rafaël Maldonado, et al.
Biological Psychiatry (2011) Vol. 71, Iss. 3, pp. 214-223
Open Access | Times Cited: 81
The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79
Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats
Luyi Zhou, Rachel J. Smith, H. Phong, et al.
Neuropharmacology (2012) Vol. 63, Iss. 7, pp. 1201-1207
Open Access | Times Cited: 77
Nicotinic Regulation of Energy Homeostasis
Michèle Zoli, Marina R. Picciotto
Nicotine & Tobacco Research (2012) Vol. 14, Iss. 11, pp. 1270-1290
Open Access | Times Cited: 76
The paraventricular nucleus of the thalamus is recruited by both natural rewards and drugs of abuse: recent evidence of a pivotal role for orexin/hypocretin signaling in this thalamic nucleus in drug-seeking behavior
Alessandra Matzeu, Eva R. Zamora-Martinez, Rémi Martin-Fardon
Frontiers in Behavioral Neuroscience (2014) Vol. 8
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top